|Patients||Presence of anti-TG2 mucosal deposits||% Positivity|
|Type 1 diabetic patients|
|Patients with untreated celiac disease||12/12||100|
|Patients with IBD||3/18||16.6|
|Patients with food allergies||0/9||0|
TG2+ type 1 diabetic patients had increased serum levels of anti-TG2 antibodies; TG2− type 1 diabetic patients had normal serum levels of anti-TG2 antibodies.